BridgeBio Pharma, Inc. Accounts Payable

Accounts Payable of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accounts Payable growth rates and interactive chart. Accounts payable (AP) represents a company's obligation to pay off a short-term debt to its creditors or suppliers. Accounts payable are amounts due to vendors or suppliers for goods or services received that have not yet been paid for. The sum of all outstanding amounts owed to vendors is shown as the accounts payable balance on the company's balance sheet. The increase or decrease in total AP from the prior period appears on the cash flow statement.

Highlights and Quick Summary

  • Accounts Payable for the quarter ending September 30, 2022 was $10.2 Million (a 15.52% increase compared to previous quarter)
  • Year-over-year quarterly Accounts Payable decreased by -14.52%
  • Annual Accounts Payable for 2021 was $11.9 Million (a 32.86% increase from previous year)
  • Annual Accounts Payable for 2020 was $8.95 Million (a 1.05% increase from previous year)
  • Annual Accounts Payable for 2019 was $8.85 Million (a -34.47% decrease from previous year)
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accounts Payable of BridgeBio Pharma, Inc.

Most recent Accounts Payableof BBIO including historical data for past 10 years.

Interactive Chart of Accounts Payable of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. Accounts Payable for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $10.16 $8.79 $10.11 –
2021 $11.88 $12.04 $22.33 $10.34 $11.88
2020 $8.95 $9.84 $12.84 $13.09 $8.95
2019 – – $8.85 $10.27 $8.85
2018 – – – $13.51 $13.51
2017 – – – – $2.0

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com